U.S. Physical Therapy Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Chris Reading
Chief executive officer
US$3.4m
Total compensation
| CEO salary percentage | 28.4% |
| CEO tenure | 20yrs |
| CEO ownership | 0.6% |
| Management average tenure | 6.7yrs |
| Board average tenure | 17.2yrs |
Recent management updates
Recent updates
Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price
Nov 09
U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively
Aug 07U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet
Jul 17U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't
Jun 04There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings
May 21U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44
May 11Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)
May 05A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)
Apr 21Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?
Apr 07U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit
Mar 04The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence
Dec 23Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching
Dec 07U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations
Oct 13Is U.S. Physical Therapy (NYSE:USPH) A Risky Investment?
Oct 13U.S. Physical Therapy (NYSE:USPH) Could Be Struggling To Allocate Capital
Sep 05Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?
Aug 15Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?
Aug 01U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)
Jul 19At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?
May 07U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price
Apr 16U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet
Apr 01Some Investors May Be Worried About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital
Mar 04U.S. Physical Therapy beats Q4 top and bottom line estimates; initiates FY23 outlook
Feb 23U.S. Physical Therapy: Needs To Illustrate Economic Reality Over Accounting Profit
Feb 12Is Now An Opportune Moment To Examine U.S. Physical Therapy, Inc. (NYSE:USPH)?
Jan 24We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt
Dec 20Here's Why We Think U.S. Physical Therapy (NYSE:USPH) Is Well Worth Watching
Dec 05U.S. Physical Therapy: Not The Most Comfortable Prospect
Nov 09CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$14m |
| Jun 30 2024 | n/a | n/a | US$16m |
| Mar 31 2024 | n/a | n/a | US$18m |
| Dec 31 2023 | US$3m | US$959k | US$18m |
| Sep 30 2023 | n/a | n/a | US$24m |
| Jun 30 2023 | n/a | n/a | US$26m |
| Mar 31 2023 | n/a | n/a | US$28m |
| Dec 31 2022 | US$2m | US$926k | US$29m |
| Sep 30 2022 | n/a | n/a | US$39m |
| Jun 30 2022 | n/a | n/a | US$38m |
| Mar 31 2022 | n/a | n/a | US$37m |
| Dec 31 2021 | US$4m | US$896k | US$31m |
| Sep 30 2021 | n/a | n/a | US$31m |
| Jun 30 2021 | n/a | n/a | US$30m |
| Mar 31 2021 | n/a | n/a | US$32m |
| Dec 31 2020 | US$3m | US$676k | US$32m |
| Sep 30 2020 | n/a | n/a | US$30m |
| Jun 30 2020 | n/a | n/a | US$31m |
| Mar 31 2020 | n/a | n/a | US$29m |
| Dec 31 2019 | US$3m | US$769k | US$31m |
| Sep 30 2019 | n/a | n/a | US$30m |
| Jun 30 2019 | n/a | n/a | US$23m |
| Mar 31 2019 | n/a | n/a | US$18m |
| Dec 31 2018 | US$3m | US$739k | US$17m |
| Sep 30 2018 | n/a | n/a | US$18m |
| Jun 30 2018 | n/a | n/a | US$22m |
| Mar 31 2018 | n/a | n/a | US$21m |
| Dec 31 2017 | US$2m | US$720k | US$22m |
Compensation vs Market: Chris's total compensation ($USD3.37M) is below average for companies of similar size in the US market ($USD5.27M).
Compensation vs Earnings: Chris's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Chris Reading (60 yo)
20yrs
Tenure
US$3,372,377
Compensation
Mr. Christopher J. Reading, also known as Chris, has been the Chief Executive Officer of US Physical Therapy Inc. since November 1, 2004 and serves as its Chairman since May 21, 2024 and served as its Pres...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 20yrs | US$3.37m | 0.63% $ 9.1m | |
| President & COO | 3.3yrs | US$1.79m | 0.11% $ 1.6m | |
| Chief Financial Officer | 4yrs | US$1.69m | 0.14% $ 2.0m | |
| Executive VP | 13.8yrs | US$1.50m | 0.085% $ 1.2m | |
| Chief Operating Officer - West | 6.7yrs | US$1.91m | 0.14% $ 2.1m | |
| Senior Vice President of Finance & Accounting | 2.6yrs | no data | no data | |
| Senior Vice President of Information Systems | no data | no data | no data | |
| Senior VP & Chief Compliance Officer | no data | no data | no data | |
| Vice President of Human Resources | no data | no data | no data | |
| VP & Corporate Controller | 18yrs | no data | no data |
6.7yrs
Average Tenure
60yo
Average Age
Experienced Management: USPH's management team is seasoned and experienced (6.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 20yrs | US$3.37m | 0.63% $ 9.1m | |
| Independent Director | 1.5yrs | US$215.92k | 0.015% $ 216.1k | |
| Independent Director | 19.8yrs | US$269.29k | 0.056% $ 797.0k | |
| Lead Independent Director | 19.3yrs | US$264.29k | 0.12% $ 1.8m | |
| Independent Director | 6.5yrs | US$256.54k | 0.13% $ 1.8m | |
| Independent Director | 17.2yrs | US$236.54k | 0.13% $ 1.8m | |
| Independent Director | 2.8yrs | US$239.04k | 0.037% $ 532.1k |
17.2yrs
Average Tenure
67yo
Average Age
Experienced Board: USPH's board of directors are seasoned and experienced ( 17.2 years average tenure).